+0.84%
Today
Loading 1D prices…
Company profile
Intellia Therapeutics Inc. Common Stock is classified in Biotechnology: In Vitro & In Vivo Diagnostic Substances within the Health Care sector.
Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
Nasdaq
Display currency
USD
Location
CAMBRIDGE, MA, United States
Fiscal year end
1231
CIK
1652130
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| IDXXIDEXX Laboratories Inc. Common Stock | $44.8B | $4.3B | +24.62% | $13.08 | +1.61% | Buy |
| LNTHLantheus Holdings Inc. Common Stock | — | $1.5B | +15.15% | $3.41 | +1.56% | Unrated |
| CLDXCelldex Therapeutics Inc. | — | $1.5M | -16748.03% | $-3.90 | -0.97% | Unrated |
| NEOGNeogen Corporation Common Stock | — | $870.4M | -0.91% | $-0.04 | -1.25% | Hold |
| NNNNAnbio Biotechnology Class A Ordinary Shares | — | $8.6M | +74.06% | $0.15 | +7.54% | Unrated |
